Renal Transplants in Hepatitis C Negative Recipients With Nucleic Acid Positive Donors
Conditions: End Stage Renal Disease; Hepatitis C Intervention: Drug: 300mg glecaprevir/pibrentasivir 120mg Sponsor: Johns Hopkins University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials